SS Innovations International Surpasses Industry Giants to Win Top Surgical Robotics Award

SS Innovations International, Inc. (NASDAQ: SSII) has been named the Outstanding Company at the 2026 Surgical Robotics Industry Awards, surpassing finalists including industry leaders Intuitive Surgical (NASDAQ: ISRG), Johnson & Johnson (NYSE: JNJ), and Medtronic (NYSE: MDT). The award recognizes a single company that demonstrates excellence in innovation, commercial success, industry leadership, and positive societal impact.

This recognition underscores SS Innovations' rapid ascent in the surgical robotics field. The company develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. Its product range includes the proprietary “SSi Mantra” surgical robotic system and the comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of procedures including cardiac surgery.

Being an American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. This award signals that the company's approach is resonating with industry experts and could potentially disrupt the market dominated by established players.

For investors and the medical technology industry, this development highlights the growing importance of cost-effective robotic surgery solutions. As healthcare systems worldwide seek to reduce costs while improving patient outcomes, companies like SS Innovations that offer affordable alternatives could see increased adoption. The award also validates the company's strategic focus on making robotic surgery more accessible, which could drive further investment and partnerships.

The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.